• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 305-23
Device Problem Gradient Increase (1270)
Patient Problems Aortic Valve Stenosis (1717); Calcium Deposits/Calcification (1758); Congestive Heart Failure (1783)
Event Date 06/01/2016
Event Type  Injury  
Manufacturer Narrative
Title: transcatheter valve unable to cure patient's prosthesis mismatch of mosaic bioprosthesis citation: thoracic and cardiovascular surgeon reports (2016) (doi 10.1055/s-0036-1583298) authors: daniela serio, andreas zierer, mirko doss, anton moritz the earliest date of e-publish/publish used for event date no unique device identifier (serial/lot) numbers were provided; without this information it cannot be determined whether this event has been previously reported.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature review that one year after the implant of this 23 mm mosaic bioprosthetic surgical aortic valve, that had been implanted due to stenosis of the native aortic valve, increased gradient measurements ( 38 mm hg) were noted.The gradients immediately post implanted were not reported.No treatment was prescribed.Three years after the implant, the patient presented with symptom of left sided heart failure.An echocardiogram indicated calcified leaflets, stenosis and increased gradient measurements.Subsequently, a non medtronic transcatheter aortic valve was implanted valve-in-valve.No adverse patient effects were reported.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC AORTIC BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key5973283
MDR Text Key55469038
Report Number2025587-2016-01513
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/30/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/23/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number305-23
Device Catalogue Number305-23
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/30/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
Patient Weight80
-
-